New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
06:03 EDTWTW, QCORStocks with implied volatility below IV index mean; WTW QCOR
Stocks with implied volatility below IV index mean; Weight Watchers (WTW) 39, Questcor (QCOR) 40 according to iVolatility.
News For WTW;QCOR From The Last 14 Days
Check below for free stories on WTW;QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
09:10 EDTQCORQuestcor expects insurance coverage for Acthar to remain favorable, consistent
Subscribe for More Information
09:10 EDTQCORQuestcor reports Q2 H.P. Acthar gel sales up 39% to $188.5M
Subscribe for More Information
09:10 EDTQCORQuestcor reports Q2 adjusted EPS $1.85, consensus $1.74
Subscribe for More Information
July 22, 2014
11:44 EDTWTWWeight Watchers August volatility elevated into Q2 and enrollment guidance
Weight Watchers August call option implied volatility is at 57, September is at 43, January is at 37; compared to its 26-week average of 44 according to Track Data, suggesting larger near term price movement into the expected release of Q2 results on July 30.
July 21, 2014
07:36 EDTQCORMallinckrodt price target raised to $95 from $85 at Jefferies
Subscribe for More Information
July 17, 2014
11:12 EDTQCOROptions with decreasing implied volatility
Subscribe for More Information
July 16, 2014
16:13 EDTQCORMallinckrodt initiated with an Outperform, $100 target at Oppenheimer
Oppenheimer believes Mallinckrodt's (MNK) acquisition of Questcor (QCOR) provides sustainable high-growth revenue potential. It believes the company bought Acthar at an attractive valuation. Opco started shares of Mallinckrodt with an Outperform rating and $100 price target.
10:35 EDTQCOROptions with decreasing implied volatility
Subscribe for More Information
July 14, 2014
15:09 EDTQCORQuestcor rises after S-4 effective, interest from other suitors disclosed
Subscribe for More Information
07:04 EDTQCORMallinckrodt and Questcor update transaction
Mallinckrodt (MNK) and Questcor (QCOR) announced that the registration statement on Form S-4 filed with the SEC by Mallinckrodt on May 16 and amended on July 11 which includes a joint proxy statement of Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt, was declared effective on July 11. The companies have also each scheduled shareholder meetings on August 14 for shareholders of record on July 9 to consider (i) in the case of Mallinckrodt, its proposal to issue its ordinary shares in connection with its proposed acquisition of Questcor and (ii) in the case of Questcor, approval of the merger agreement with Mallinckrodt and related matters. The transaction is currently expected to be completed in August.
July 11, 2014
11:31 EDTWTWOptions with increasing implied volatility
Options with increasing implied volatility: INO AEGR UBNT INVN WTW OREX GNC CREE SD SAN
09:09 EDTQCOROn The Fly: Pre-market Movers
Subscribe for More Information
06:39 EDTQCORQuestcor reports Acthar adverse effects data, NY Times says
The number of patients who reported an adverse effect last year while taking Questcor's (QCOR) Acthar drug amounted to almost 5% of prescriptions dispensed, the company stated in a regulatory filing released yesterday, according to The New York Times. The filing marked the first time that the company has disclosed any difficulties experienced by Acthar patients, the newspaper added. Questcor has agreed to be bought by Mallinckrodt (MNK). Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use